Highlights

array(40) {
  [0]=>
  string(4) "3836"
  ["article_id"]=>
  string(4) "3836"
  [1]=>
  string(63) "International Conference on e-Health and Healthcare Innovations"
  ["article_title"]=>
  string(63) "International Conference on e-Health and Healthcare Innovations"
  [2]=>
  string(150) "e-Health, e-Health Applications, Electronic Medical Records, Electronic Health Records, Telemedicine, Allopathy Medicine, Mobile Health, Ayurvedic Med"
  ["short_description"]=>
  string(150) "e-Health, e-Health Applications, Electronic Medical Records, Electronic Health Records, Telemedicine, Allopathy Medicine, Mobile Health, Ayurvedic Med"
  [3]=>
  string(390) "e-Health, e-Health Applications, Electronic Medical Records, Electronic Health Records, Telemedicine, Allopathy Medicine, Mobile Health, Ayurvedic Medicine, Homeopathy Medicine, Over-the-Counter Drugs, Prescription Drugs, Consumer Health Informatics, Health IT Systems, Virtual Healthcare, Health data Security, e-Prescription,, Disease Management, Medical Devices, Digital Health "
  ["description"]=>
  string(390) "e-Health, e-Health Applications, Electronic Medical Records, Electronic Health Records, Telemedicine, Allopathy Medicine, Mobile Health, Ayurvedic Medicine, Homeopathy Medicine, Over-the-Counter Drugs, Prescription Drugs, Consumer Health Informatics, Health IT Systems, Virtual Healthcare, Health data Security, e-Prescription,, Disease Management, Medical Devices, Digital Health "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "59"
  ["rss_id"]=>
  string(2) "59"
  [14]=>
  string(112) "
https://www.pharmiweb.com/event/international-conference-on-e-health-and-healthcare-innovations                "
  ["blog_url"]=>
  string(112) "
https://www.pharmiweb.com/event/international-conference-on-e-health-and-healthcare-innovations                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-07-22 17:53:40"
  ["create_at"]=>
  string(19) "2019-07-22 17:53:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

International Conference on e-Health and Healthcare Innovations

e-Health, e-Health Applications, Electronic Medical Records, Electronic Health Records, Telemedicine, Allopathy Medicine

array(40) {
  [0]=>
  string(4) "3837"
  ["article_id"]=>
  string(4) "3837"
  [1]=>
  string(58) "14th International Conference on Biologics and Biosimilars"
  ["article_title"]=>
  string(58) "14th International Conference on Biologics and Biosimilars"
  [2]=>
  string(150) "14th International Conference on Biologics and Biosimilars is scheduled to held on August 2-3, 2019 in Chicago, USA. On behalf of the Organizing Commi"
  ["short_description"]=>
  string(150) "14th International Conference on Biologics and Biosimilars is scheduled to held on August 2-3, 2019 in Chicago, USA. On behalf of the Organizing Commi"
  [3]=>
  string(512) "14th International Conference on Biologics and Biosimilars is scheduled to held on August 2-3, 2019 in Chicago, USA. On behalf of the Organizing Committee we welcome you all to join us once again in this elaborately planned Conference which is going to host Keynote Sessions, Plenary sessions, Posters Presentations, Exhibitions and Career Development Programs.Biosimilars 2019 Conference is a one of a kind conference where we will be focusing on Biosimilars potential to change the Pharmaceutical w…"
  ["description"]=>
  string(512) "14th International Conference on Biologics and Biosimilars is scheduled to held on August 2-3, 2019 in Chicago, USA. On behalf of the Organizing Committee we welcome you all to join us once again in this elaborately planned Conference which is going to host Keynote Sessions, Plenary sessions, Posters Presentations, Exhibitions and Career Development Programs.Biosimilars 2019 Conference is a one of a kind conference where we will be focusing on Biosimilars potential to change the Pharmaceutical w…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "59"
  ["rss_id"]=>
  string(2) "59"
  [14]=>
  string(107) "
https://www.pharmiweb.com/event/14th-international-conference-on-biologics-and-biosimilars                "
  ["blog_url"]=>
  string(107) "
https://www.pharmiweb.com/event/14th-international-conference-on-biologics-and-biosimilars                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-07-22 17:53:40"
  ["create_at"]=>
  string(19) "2019-07-22 17:53:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

14th International Conference on Biologics and Biosimilars

14th International Conference on Biologics and Biosimilars is scheduled to held on August 2-3, 2019 in Chicago, USA. On

array(40) {
  [0]=>
  string(4) "3838"
  ["article_id"]=>
  string(4) "3838"
  [1]=>
  string(78) "2nd International Conference on Pharmaceutical Analysis & Analytical Chemistry"
  ["article_title"]=>
  string(78) "2nd International Conference on Pharmaceutical Analysis & Analytical Chemistry"
  [2]=>
  string(150) "After the fruitful execution of the International Conference on Pharmaceutical Analysis and Quality Control Strategies, Conference Series with great p"
  ["short_description"]=>
  string(150) "After the fruitful execution of the International Conference on Pharmaceutical Analysis and Quality Control Strategies, Conference Series with great p"
  [3]=>
  string(526) "After the fruitful execution of the International Conference on Pharmaceutical Analysis and Quality Control Strategies, Conference Series with great pride and honour announcing its 2nd  International Conference on Pharmaceutical Analysis & Analytical Chemistry which is going to held in Chicago, USA during August 02-03, 2019.&#nl&#nlPharmaceutical Analysis 2019 serves as a podium for the interaction between experts in the area of pharmaceutical analysis and analytical chemistry around the worl…"
  ["description"]=>
  string(526) "After the fruitful execution of the International Conference on Pharmaceutical Analysis and Quality Control Strategies, Conference Series with great pride and honour announcing its 2nd  International Conference on Pharmaceutical Analysis & Analytical Chemistry which is going to held in Chicago, USA during August 02-03, 2019.&#nl&#nlPharmaceutical Analysis 2019 serves as a podium for the interaction between experts in the area of pharmaceutical analysis and analytical chemistry around the worl…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "59"
  ["rss_id"]=>
  string(2) "59"
  [14]=>
  string(125) "
https://www.pharmiweb.com/event/2nd-international-conference-on-pharmaceutical-analysis-analytical-chemistry                "
  ["blog_url"]=>
  string(125) "
https://www.pharmiweb.com/event/2nd-international-conference-on-pharmaceutical-analysis-analytical-chemistry                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-07-22 17:53:40"
  ["create_at"]=>
  string(19) "2019-07-22 17:53:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

2nd International Conference on Pharmaceutical Analysis & Analytical Chemistry

After the fruitful execution of the International Conference on Pharmaceutical Analysis and Quality Control Strategies,

array(40) {
  [0]=>
  string(4) "3839"
  ["article_id"]=>
  string(4) "3839"
  [1]=>
  string(28) "Pharmaceutical Analysis 2019"
  ["article_title"]=>
  string(28) "Pharmaceutical Analysis 2019"
  [2]=>
  string(150) "After the fruitful execution of the International Conference on Pharmaceutical Analysis and Quality Control Strategies, Conference Series with great p"
  ["short_description"]=>
  string(150) "After the fruitful execution of the International Conference on Pharmaceutical Analysis and Quality Control Strategies, Conference Series with great p"
  [3]=>
  string(526) "After the fruitful execution of the International Conference on Pharmaceutical Analysis and Quality Control Strategies, Conference Series with great pride and honour announcing its 2nd  International Conference on Pharmaceutical Analysis & Analytical Chemistry which is going to held in Chicago, USA during August 02-03, 2019.&#nl&#nlPharmaceutical Analysis 2019 serves as a podium for the interaction between experts in the area of pharmaceutical analysis and analytical chemistry around the worl…"
  ["description"]=>
  string(526) "After the fruitful execution of the International Conference on Pharmaceutical Analysis and Quality Control Strategies, Conference Series with great pride and honour announcing its 2nd  International Conference on Pharmaceutical Analysis & Analytical Chemistry which is going to held in Chicago, USA during August 02-03, 2019.&#nl&#nlPharmaceutical Analysis 2019 serves as a podium for the interaction between experts in the area of pharmaceutical analysis and analytical chemistry around the worl…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "59"
  ["rss_id"]=>
  string(2) "59"
  [14]=>
  string(77) "
https://www.pharmiweb.com/event/pharmaceutical-analysis-2019                "
  ["blog_url"]=>
  string(77) "
https://www.pharmiweb.com/event/pharmaceutical-analysis-2019                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-07-22 17:53:40"
  ["create_at"]=>
  string(19) "2019-07-22 17:53:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Pharmaceutical Analysis 2019

After the fruitful execution of the International Conference on Pharmaceutical Analysis and Quality Control Strategies,

array(40) {
  [0]=>
  string(4) "3840"
  ["article_id"]=>
  string(4) "3840"
  [1]=>
  string(89) "Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)"
  ["article_title"]=>
  string(89) "Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)"
  [2]=>
  string(150) "This seminar will help all personnel responsible for CMO oversight understand how to manage CMOs- from start to finish. In-depth focus will be placed "
  ["short_description"]=>
  string(150) "This seminar will help all personnel responsible for CMO oversight understand how to manage CMOs- from start to finish. In-depth focus will be placed "
  [3]=>
  string(511) "This seminar will help all personnel responsible for CMO oversight understand how to manage CMOs- from start to finish. In-depth focus will be placed on Selection and Qualification, Quality Agreements, Understanding of CMO Operations, and Review of Key CMO Records. Considerations for different types of manufacturing will be highlighted, and techniques for managing difficult CMO situations will be discussed. This is a practical how-to course, designed to provide participants with skills they can…"
  ["description"]=>
  string(511) "This seminar will help all personnel responsible for CMO oversight understand how to manage CMOs- from start to finish. In-depth focus will be placed on Selection and Qualification, Quality Agreements, Understanding of CMO Operations, and Review of Key CMO Records. Considerations for different types of manufacturing will be highlighted, and techniques for managing difficult CMO situations will be discussed. This is a practical how-to course, designed to provide participants with skills they can…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "59"
  ["rss_id"]=>
  string(2) "59"
  [14]=>
  string(136) "
https://www.pharmiweb.com/event/effective-quality-oversight-of-pharmaceutical-contract-manufacturing-organizations-cmos                "
  ["blog_url"]=>
  string(136) "
https://www.pharmiweb.com/event/effective-quality-oversight-of-pharmaceutical-contract-manufacturing-organizations-cmos                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-07-22 17:53:40"
  ["create_at"]=>
  string(19) "2019-07-22 17:53:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

This seminar will help all personnel responsible for CMO oversight understand how to manage CMOs- from start to finish.

array(40) {
  [0]=>
  string(4) "3841"
  ["article_id"]=>
  string(4) "3841"
  [1]=>
  string(60) "International Expo on Analytical Sciences & Instrumentation "
  ["article_title"]=>
  string(60) "International Expo on Analytical Sciences & Instrumentation "
  [2]=>
  string(156) "International Expo on Analytical Sciences & Instrumentation (Analytica-2019)&#nl&#nlis going to be held during August 1-2, 2019 at&nbsp"
  ["short_description"]=>
  string(156) "International Expo on Analytical Sciences & Instrumentation (Analytica-2019)&#nl&#nlis going to be held during August 1-2, 2019 at&nbsp"
  [3]=>
  string(671) "International Expo on Analytical Sciences & Instrumentation (Analytica-2019)&#nl&#nlis going to be held during August 1-2, 2019 at Valencia, Spain. Analytical Chemistry-2019 bring upon a new platform to share and discuss all the innovations in the Analytical Chemistry.&#nl&#nl                                   &#nlAnalytical Chemistry…"
  ["description"]=>
  string(671) "International Expo on Analytical Sciences & Instrumentation (Analytica-2019)&#nl&#nlis going to be held during August 1-2, 2019 at Valencia, Spain. Analytical Chemistry-2019 bring upon a new platform to share and discuss all the innovations in the Analytical Chemistry.&#nl&#nl                                   &#nlAnalytical Chemistry…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "59"
  ["rss_id"]=>
  string(2) "59"
  [14]=>
  string(106) "
https://www.pharmiweb.com/event/international-expo-on-analytical-sciences-instrumentation                "
  ["blog_url"]=>
  string(106) "
https://www.pharmiweb.com/event/international-expo-on-analytical-sciences-instrumentation                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-07-22 17:53:40"
  ["create_at"]=>
  string(19) "2019-07-22 17:53:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

International Expo on Analytical Sciences & Instrumentation

International Expo on Analytical Sciences & Instrumentation (Analytica-2019)&#nl&#nlis going to be held during A

array(40) {
  [0]=>
  string(4) "3999"
  ["article_id"]=>
  string(4) "3999"
  [1]=>
  string(72) "Kedrion Biopharma announces enrollment of first patient in CARES10 trial"
  ["article_title"]=>
  string(72) "Kedrion Biopharma announces enrollment of first patient in CARES10 trial"
  [2]=>
  string(150) "CARES10 is a United States/Canada-based open-label, prospective, multi-center phase 3 clinical study to assess efficacy, safety and pharmacokinetics o"
  ["short_description"]=>
  string(150) "CARES10 is a United States/Canada-based open-label, prospective, multi-center phase 3 clinical study to assess efficacy, safety and pharmacokinetics o"
  [3]=>
  string(628) "

CARES10 is a United States/Canada-based open-label, prospective, multi-center phase 3 clinical study to assess efficacy, safety and pharmacokinetics of a 10 percent intravenous immunoglobulin in the treatment of

&#nl

The post Kedrion Biopharma announces enrollment of first patient in CARES10 trial appeared first on Pharmaceutical Business review.

&#nl" ["description"]=> string(628) "

CARES10 is a United States/Canada-based open-label, prospective, multi-center phase 3 clinical study to assess efficacy, safety and pharmacokinetics of a 10 percent intravenous immunoglobulin in the treatment of

&#nl

The post Kedrion Biopharma announces enrollment of first patient in CARES10 trial appeared first on Pharmaceutical Business review.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "30" ["rss_id"]=> string(2) "30" [14]=> string(125) "https://www.pharmaceutical-business-review.com/news/kedrion-biopharma-announces-enrollment-of-first-patient-in-cares10-trial/" ["blog_url"]=> string(125) "https://www.pharmaceutical-business-review.com/news/kedrion-biopharma-announces-enrollment-of-first-patient-in-cares10-trial/" [15]=> string(19) "1970-01-01 07:30:00" ["add_date"]=> string(19) "1970-01-01 07:30:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-08-14 10:54:57" ["create_at"]=> string(19) "2019-08-14 10:54:57" [19]=> string(0) "" ["slug"]=> string(0) "" }

Kedrion Biopharma announces enrollment of first patient in CARES10 trial

CARES10 is a United States/Canada-based open-label, prospective, multi-center phase 3 clinical study to assess effica

array(40) {
  [0]=>
  string(4) "4000"
  ["article_id"]=>
  string(4) "4000"
  [1]=>
  string(99) "Eidos Therapeutics confirms receipt of non-binding proposal from BridgeBio Pharma to acquire shares"
  ["article_title"]=>
  string(99) "Eidos Therapeutics confirms receipt of non-binding proposal from BridgeBio Pharma to acquire shares"
  [2]=>
  string(155) "BridgeBio currently owns, through its wholly-owned subsidiary, BridgeBio Pharma LLC, approximately 66.6% of the outstanding shares of the Company’s "
  ["short_description"]=>
  string(155) "BridgeBio currently owns, through its wholly-owned subsidiary, BridgeBio Pharma LLC, approximately 66.6% of the outstanding shares of the Company’s "
  [3]=>
  string(679) "

BridgeBio currently owns, through its wholly-owned subsidiary, BridgeBio Pharma LLC, approximately 66.6% of the outstanding shares of the Company’s common stock. According to the terms of the Proposal,

&#nl

The post Eidos Therapeutics confirms receipt of non-binding proposal from BridgeBio Pharma to acquire shares appeared first on Pharmaceutical Business review.

&#nl" ["description"]=> string(679) "

BridgeBio currently owns, through its wholly-owned subsidiary, BridgeBio Pharma LLC, approximately 66.6% of the outstanding shares of the Company’s common stock. According to the terms of the Proposal,

&#nl

The post Eidos Therapeutics confirms receipt of non-binding proposal from BridgeBio Pharma to acquire shares appeared first on Pharmaceutical Business review.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "30" ["rss_id"]=> string(2) "30" [14]=> string(152) "https://www.pharmaceutical-business-review.com/news/eidos-therapeutics-confirms-receipt-of-non-binding-proposal-from-bridgebio-pharma-to-acquire-shares/" ["blog_url"]=> string(152) "https://www.pharmaceutical-business-review.com/news/eidos-therapeutics-confirms-receipt-of-non-binding-proposal-from-bridgebio-pharma-to-acquire-shares/" [15]=> string(19) "1970-01-01 07:30:00" ["add_date"]=> string(19) "1970-01-01 07:30:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-08-14 10:54:57" ["create_at"]=> string(19) "2019-08-14 10:54:57" [19]=> string(0) "" ["slug"]=> string(0) "" }

Eidos Therapeutics confirms receipt of non-binding proposal from BridgeBio Pharma to acqui

BridgeBio currently owns, through its wholly-owned subsidiary, BridgeBio Pharma LLC, approximately 66.6% of the outst

array(40) {
  [0]=>
  string(4) "4001"
  ["article_id"]=>
  string(4) "4001"
  [1]=>
  string(64) "Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m"
  ["article_title"]=>
  string(64) "Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m"
  [2]=>
  string(152) "As per terms of the deal, the former Cavion shareholders have secured an upfront payment of $52.5m (£43.5m). They are also eligible to receive additi"
  ["short_description"]=>
  string(152) "As per terms of the deal, the former Cavion shareholders have secured an upfront payment of $52.5m (£43.5m). They are also eligible to receive additi"
  [3]=>
  string(539) "

As per terms of the deal, the former Cavion shareholders have secured an upfront payment of $52.5m (£43.5m). They are also eligible to receive additional payments of around

&#nl

The post Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m appeared first on Pharmaceutical Business review.

&#nl" ["description"]=> string(539) "

As per terms of the deal, the former Cavion shareholders have secured an upfront payment of $52.5m (£43.5m). They are also eligible to receive additional payments of around

&#nl

The post Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m appeared first on Pharmaceutical Business review.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "30" ["rss_id"]=> string(2) "30" [14]=> string(80) "https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-cavion/" ["blog_url"]=> string(80) "https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-cavion/" [15]=> string(19) "1970-01-01 07:30:00" ["add_date"]=> string(19) "1970-01-01 07:30:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-08-14 10:54:57" ["create_at"]=> string(19) "2019-08-14 10:54:57" [19]=> string(0) "" ["slug"]=> string(0) "" }

Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m

As per terms of the deal, the former Cavion shareholders have secured an upfront payment of $52.5m (£43.5m). They

array(40) {
  [0]=>
  string(4) "4002"
  ["article_id"]=>
  string(4) "4002"
  [1]=>
  string(51) "Ascletis opens Clinical Development Shanghai Center"
  ["article_title"]=>
  string(51) "Ascletis opens Clinical Development Shanghai Center"
  [2]=>
  string(150) "Ascletis’ Clinical Development Shanghai Center is at the heart of Shanghai, located at Jing’an Kerry Centre near Nanjing West Road. The op"
  ["short_description"]=>
  string(150) "Ascletis’ Clinical Development Shanghai Center is at the heart of Shanghai, located at Jing’an Kerry Centre near Nanjing West Road. The op"
  [3]=>
  string(559) "

Ascletis’ Clinical Development Shanghai Center is at the heart of Shanghai, located at Jing’an Kerry Centre near Nanjing West Road. The opening ceremony was held on Aug 11,

&#nl

The post Ascletis opens Clinical Development Shanghai Center appeared first on Pharmaceutical Business review.

&#nl" ["description"]=> string(559) "

Ascletis’ Clinical Development Shanghai Center is at the heart of Shanghai, located at Jing’an Kerry Centre near Nanjing West Road. The opening ceremony was held on Aug 11,

&#nl

The post Ascletis opens Clinical Development Shanghai Center appeared first on Pharmaceutical Business review.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "30" ["rss_id"]=> string(2) "30" [14]=> string(104) "https://www.pharmaceutical-business-review.com/news/ascletis-opens-clinical-development-shanghai-center/" ["blog_url"]=> string(104) "https://www.pharmaceutical-business-review.com/news/ascletis-opens-clinical-development-shanghai-center/" [15]=> string(19) "1970-01-01 07:30:00" ["add_date"]=> string(19) "1970-01-01 07:30:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-08-14 10:54:57" ["create_at"]=> string(19) "2019-08-14 10:54:57" [19]=> string(0) "" ["slug"]=> string(0) "" }

Ascletis opens Clinical Development Shanghai Center

Ascletis’ Clinical Development Shanghai Center is at the heart of Shanghai, located at Jing’an Kerry Cent

array(40) {
  [0]=>
  string(4) "4003"
  ["article_id"]=>
  string(4) "4003"
  [1]=>
  string(75) "Neoleukin Therapeutics, Aquinox Pharmaceuticals complete merger transaction"
  ["article_title"]=>
  string(75) "Neoleukin Therapeutics, Aquinox Pharmaceuticals complete merger transaction"
  [2]=>
  string(158) "Aquinox Pharmaceuticals, Inc. will be renamed Neoleukin Therapeutics, Inc. and will trade under the new ticker symbol “NLTX” beginning on Monday, "
  ["short_description"]=>
  string(158) "Aquinox Pharmaceuticals, Inc. will be renamed Neoleukin Therapeutics, Inc. and will trade under the new ticker symbol “NLTX” beginning on Monday, "
  [3]=>
  string(617) "

Aquinox Pharmaceuticals, Inc. will be renamed Neoleukin Therapeutics, Inc. and will trade under the new ticker symbol “NLTX” beginning on Monday, August 12, 2019, on the Nasdaq Global

&#nl

The post Neoleukin Therapeutics, Aquinox Pharmaceuticals complete merger transaction appeared first on Pharmaceutical Business review.

&#nl" ["description"]=> string(617) "

Aquinox Pharmaceuticals, Inc. will be renamed Neoleukin Therapeutics, Inc. and will trade under the new ticker symbol “NLTX” beginning on Monday, August 12, 2019, on the Nasdaq Global

&#nl

The post Neoleukin Therapeutics, Aquinox Pharmaceuticals complete merger transaction appeared first on Pharmaceutical Business review.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "30" ["rss_id"]=> string(2) "30" [14]=> string(127) "https://www.pharmaceutical-business-review.com/news/neoleukin-therapeutics-aquinox-pharmaceuticals-complete-merger-transaction/" ["blog_url"]=> string(127) "https://www.pharmaceutical-business-review.com/news/neoleukin-therapeutics-aquinox-pharmaceuticals-complete-merger-transaction/" [15]=> string(19) "1970-01-01 07:30:00" ["add_date"]=> string(19) "1970-01-01 07:30:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-08-14 10:54:57" ["create_at"]=> string(19) "2019-08-14 10:54:57" [19]=> string(0) "" ["slug"]=> string(0) "" }

Neoleukin Therapeutics, Aquinox Pharmaceuticals complete merger transaction

Aquinox Pharmaceuticals, Inc. will be renamed Neoleukin Therapeutics, Inc. and will trade under the new ticker symbol

array(40) {
  [0]=>
  string(4) "4004"
  ["article_id"]=>
  string(4) "4004"
  [1]=>
  string(79) "Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi"
  ["article_title"]=>
  string(79) "Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi"
  [2]=>
  string(150) "The United States District Court of New Jersey gave ruling against Sandoz over the validity of the two patents that describe and claim Enbrel and the "
  ["short_description"]=>
  string(150) "The United States District Court of New Jersey gave ruling against Sandoz over the validity of the two patents that describe and claim Enbrel and the "
  [3]=>
  string(546) "

The United States District Court of New Jersey gave ruling against Sandoz over the validity of the two patents that describe and claim Enbrel and the methods for

&#nl

The post Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi appeared first on Pharmaceutical Business review.

&#nl" ["description"]=> string(546) "

The United States District Court of New Jersey gave ruling against Sandoz over the validity of the two patents that describe and claim Enbrel and the methods for

&#nl

The post Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi appeared first on Pharmaceutical Business review.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "30" ["rss_id"]=> string(2) "30" [14]=> string(86) "https://www.pharmaceutical-business-review.com/news/sandoz-erelzi-patent-infringement/" ["blog_url"]=> string(86) "https://www.pharmaceutical-business-review.com/news/sandoz-erelzi-patent-infringement/" [15]=> string(19) "1970-01-01 07:30:00" ["add_date"]=> string(19) "1970-01-01 07:30:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-08-14 10:54:57" ["create_at"]=> string(19) "2019-08-14 10:54:57" [19]=> string(0) "" ["slug"]=> string(0) "" }

Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi

The United States District Court of New Jersey gave ruling against Sandoz over the validity of the two patents that d